Implementation science in pediatric oncology: A narrative review and future directions

Pediatr Blood Cancer. 2022 Apr;69(4):e29579. doi: 10.1002/pbc.29579. Epub 2022 Jan 19.

Abstract

Implementation science (IS) has garnered attention within oncology, and most prior IS work has focused on adult, not pediatric, oncology. This narrative review broadly characterizes IS for pediatric oncology. It includes studies through 2020 using the following search terms in PubMed, Ovid Medline, and Cochrane: "implementation science," "pediatric," "childhood," "cancer," and "oncology." Systematic review was not performed due to the limited number of heterogeneous studies. Of 216 articles initially reviewed, nine were selected as specific to IS and pediatric oncology. All nine examined oncologic supportive care, cancer prevention, or cancer control. The supportive care focus is potentially due to the presence of cooperative study groups such as the Children's Oncology Group, which efficiently drive cancer-directed therapy changes through clinical trials. Future IS within pediatric oncology should embrace this ecosystem and focus on cancer control interventions that benefit patients across multiple cancer types and patients treated outside cooperative group studies.

Keywords: implementation science; pediatric cancer; pediatric oncology; supportive care.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adult
  • Child
  • Ecosystem
  • Humans
  • Implementation Science*
  • Medical Oncology
  • Neoplasms* / prevention & control